Literature DB >> 31175080

A Combination of Change in Albuminuria and GFR as a Surrogate End Point for Progression of CKD.

Josef Coresh1, Andrew S Levey2.   

Abstract

Entities:  

Keywords:  Biomarkers; Disease Progression; Renal Insufficiency, Chronic; albuminuria

Mesh：

Substances：

Year:  2019        PMID： 31175080      PMCID： PMC6556711          DOI： 10.2215/CJN.04160419

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 2.  GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

Authors:  Andrew S Levey; Lesley A Inker; Kunihiro Matsushita; Tom Greene; Kerry Willis; Edmund Lewis; Dick de Zeeuw; Alfred K Cheung; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-10-16       Impact factor: 8.860

Review 3.  Action plan for optimizing the design of clinical trials in chronic kidney disease.

Authors:  Vlado Perkovic; Jonathan C Craig; Worawon Chailimpamontree; Caroline S Fox; Guillermo Garcia-Garcia; Mohammed Benghanem Gharbi; Meg J Jardine; Ikechi G Okpechi; Neesh Pannu; Benedicte Stengel; Katherine R Tuttle; Katrin Uhlig; Andrew S Levey
Journal:  Kidney Int Suppl (2011)       Date:  2017-09-20

4.  Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Authors:  Toshiaki Ohkuma; Min Jun; John Chalmers; Mark E Cooper; Pavel Hamet; Stephen Harrap; Sophia Zoungas; Vlado Perkovic; Mark Woodward
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-03       Impact factor: 8.237

5.  Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Authors:  Josef Coresh; Hiddo J L Heerspink; Yingying Sang; Kunihiro Matsushita; Johan Arnlov; Brad C Astor; Corri Black; Nigel J Brunskill; Juan-Jesus Carrero; Harold I Feldman; Caroline S Fox; Lesley A Inker; Areef Ishani; Sadayoshi Ito; Simerjot Jassal; Tsuneo Konta; Kevan Polkinghorne; Solfrid Romundstad; Marit D Solbu; Nikita Stempniewicz; Benedicte Stengel; Marcello Tonelli; Mitsumasa Umesawa; Sushrut S Waikar; Chi-Pang Wen; Jack F M Wetzels; Mark Woodward; Morgan E Grams; Csaba P Kovesdy; Andrew S Levey; Ron T Gansevoort
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-08       Impact factor: 32.069

6.  Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Authors:  Hiddo J L Heerspink; Tom Greene; Hocine Tighiouart; Ron T Gansevoort; Josef Coresh; Andrew L Simon; Tak Mao Chan; Fan Fan Hou; Julia B Lewis; Francesco Locatelli; Manuel Praga; Francesco Paolo Schena; Andrew S Levey; Lesley A Inker
Journal:  Lancet Diabetes Endocrinol       Date:  2019-01-08       Impact factor: 32.069

7.  Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Authors:  Anushka Patel; S MacMahon; J Chalmers; B Neal; M Woodward; L Billot; S Harrap; N Poulter; M Marre; M Cooper; P Glasziou; D E Grobbee; P Hamet; S Heller; L S Liu; G Mancia; C E Mogensen; C Y Pan; A Rodgers; B Williams
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

8.  Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.

Authors:  Min Jun; Toshiaki Ohkuma; Sophia Zoungas; Stephen Colagiuri; Giuseppe Mancia; Michel Marre; David Matthews; Neil Poulter; Bryan Williams; Anthony Rodgers; Vlado Perkovic; John Chalmers; Mark Woodward
Journal:  Diabetes Care       Date:  2017-10-27       Impact factor: 19.112

9.  Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

Authors:  Vlado Perkovic; Hiddo Lambers Heerspink; John Chalmers; Mark Woodward; Min Jun; Qiang Li; Stephen MacMahon; Mark E Cooper; Pavel Hamet; Michel Marre; Carl Erik Mogensen; Neil Poulter; Giuseppe Mancia; Alan Cass; Anushka Patel; Sophia Zoungas
Journal:  Kidney Int       Date:  2013-01-09       Impact factor: 10.612

10.  Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Authors:  Sophia Zoungas; John Chalmers; Bruce Neal; Laurent Billot; Qiang Li; Yoichiro Hirakawa; Hisatomi Arima; Helen Monaghan; Rohina Joshi; Stephen Colagiuri; Mark E Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Liu Lisheng; Giuseppe Mancia; Michel Marre; David R Matthews; Carl E Mogensen; Vlado Perkovic; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; Anushka Patel; Mark Woodward
Journal:  N Engl J Med       Date:  2014-09-19       Impact factor: 91.245
  10 in total
  2 in total

1.  Could outcomes of intracranial aneurysms be better predict using serum creatinine and glomerular filtration rate?

Authors:  Nícollas Nunes Rabelo; Leonardo Zumerkorn Pipek; Rafaela Farias Vidigal Nascimento; João Paulo Mota Telles; Natalia Camargo Barbato; Antônio Carlos Samaia da Silva Coelho; Guilherme Bitencourt Barbosa; Marcia Harumy Yoshikawa; Manoel Jacobsen Teixeira; Eberval Gadelha Figueiredo
Journal:  Acta Cir Bras       Date:  2022-04-08       Impact factor: 1.388

Review 2.  Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.

Authors:  Janet B McGill; Hermann Haller; Prabir Roy-Chaudhury; Andrea Cherrington; Takashi Wada; Christoph Wanner; Linong Ji; Peter Rossing
Journal:  BMJ Open Diabetes Res Care       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.